Artefactum

OCT 19, 2026 · JOURNAL ARTICLE

EPIDEMIOLOGY AND TEMPORAL TRENDS OF SYPHILIS AMONG INDIGENOUS CHILDREN UNDER ONE YEAR OF AGE IN AMAZONAS, BRAZIL, FROM 2021 TO 2025

Artefactum

Introduction: Among the most common health conditions affecting Indigenous peoples since the arrival of European colonizers are sexually transmitted infections (STIs), including sy

OCT 16, 2026 · JOURNAL ARTICLE

Physiotherapeutic approaches and integrative therapies in the outpatient treatment of children with cancer: a literature review

Artefactum

Childhood cancer can cause physical and emotional limitations that affect the child’s routine and quality of life. In this context, physiotherapy and integrative therapies support

OCT 13, 2026 · JOURNAL ARTICLE

CRITICAL ANALYSIS OF THE FEASIBILITY OF USING ARTIFICIAL INTELLIGENCE TOOLS THROUGH THE LENS OF THE BRAZILIAN SOCIETY OF INFECTIOUS DISEASES GUIDELINES FOR ANTIMICROBIAL STEWARDSHIP IN GRAM-NEGATIVE BACTERIAL INFECTIONS

Artefactum

The global emergence of multidrug-resistant Gram-negative bacilli represents one of the major global public health challenges today, requiring structured interventions for antimicr

OCT 8, 2026 · JOURNAL ARTICLE

THE NEW SURGICAL PATIENT IN THE ERA OF GLP-1 RECEPTOR AGONISTS: PERIOPERATIVE IMPLICATIONS AND EMERGING CHALLENGES FOR ABDOMINAL SURGERY

Artefactum

The use of glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for type 2 diabetes mellitus and now widely prescribed for obesity, has changed the profile of pa

SEP 30, 2026 · REVIEW

POLYCYSTIC OVARY SYNDROME: METABOLIC REPERCUSSIONS AND IMPACT ON FERTILITY — A NARRATIVE REVIEW

Artefactum

Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder in which reproductive dysfunction and metabolic abnormalities frequently coexist, making infertility assessme

AUG 20, 2026 · JOURNAL ARTICLE

APPLICATION OF THE CRISPR-CAS9 SYSTEM IN BIRC5 GENE MODULATION IN TRIPLE-NEGATIVE BREAST CANCER: A REVIEW

Artefactum

A literature review synthesizing preclinical and mechanistic evidence on CRISPR-Cas9 for BIRC5 modulation in TNBC; raises therapeutic potential but acknowledges unresolved technical barriers and lack of clinical translation.